Evogene Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023
28 February 2023, Israel: Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development announced today that it will release its financial results for the fourth quarter and full year 2022 on Thursday, March 9, 2023.
Later that day, Company management will host a conference call to discuss the results at 9:00AM Eastern time, 4:00 PM Israel time.
To access the conference call, please dial +1-888-281-1167 toll free from the United States, or +972-3-918-0609 internationally. Access to the call will also be available via live webcast through the Company’s website at www.evogene.com.
A replay of the conference call will be available approximately two hours following the completion of the call. To access the replay, please dial +1-888-326-9310 toll free from the United States, or +972-3-925-5901 internationally. The telephone replay will be accessible for three days, but an archive of the webcast will be available on the webcast link for the following twelve months.
Also Read: Union Budget 2023: An Overview of the Focus on Agriculture
(For Latest Agriculture News & Updates, follow Krishak Jagat on Google News)